The Use of a Modified Blood Pressure Device to Detect Atrial Fibrillation in Outpatients

The prevalence and integration of self-monitoring devices is increasing across healthcare systems, [1] and this is leading to patients taking greater responsibility for their health and well-being. Our aim was to compare two groups of patients with reoccurring atrial fibrillation (AF) and their ability to detect AF with the Microlife BP A6 device. The groups were divided according to being symptomatic or asymptomatic for AF. Method: The study was conducted for 3 years. The patients were selected from Kaunas clinical hospital in Kaunas, Lithuania. In total, 60 people took part in the study. The major criterion for inclusion was based on patients having AF upon arrival. During the period of hospitalisation, they were restored to having sinusoidal rhythm (SR). There were two groups of patients in the study. The first group had clear symptoms during the onset of rhythm disturbance and the second group was asymptomatic. All patients under the age of 18 years and those who did not sign the agreement to participate were excluded from the study. The patients were contacted every 6 months by phone call and a questionnaire was filled. The statistical analysis was performed using SPSS 23 and Microsoft Office Excel 2007 software. The results were deemed statistically significant when p<0.05. Results: There is a statistical difference between the symptomatic and asymptomatic AF patients as compared to how useful they found the device and its effect on anxiety (p<0.05). There was no statistical difference between the two groups on how frequently they used the device. The research also shows that there was no difference based on gender, education levels. Conclusion: There is a statistically significant portion of AF asymptomatic patients that find the Microlife BP A6 “very useful” and an anxiety reliever as compared to patients that are symptomatic for the condition. Both groups have statistically equally poor adherence in using the device at home.

[1]  S. Ceccherini,et al.  Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  N. Lowres,et al.  Self-monitoring for atrial fibrillation recurrence in the discharge period post-cardiac surgery using an iPhone electrocardiogram. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  J. Wiesel,et al.  Detection of atrial fibrillation using a modified microlife blood pressure monitor. , 2009, American journal of hypertension.

[4]  F. Cappuccio,et al.  Blood pressure control by home monitoring: meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[5]  Natalie Pearson,et al.  Devices for Self-Monitoring Sedentary Time or Physical Activity: A Scoping Review , 2016, Journal of medical Internet research.

[6]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  C. Harada,et al.  Normal cognitive aging. , 2013, Clinics in geriatric medicine.

[8]  Mitsuru Ishii,et al.  Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events , 2018, Stroke.

[9]  S. Antoniou,et al.  Current Situation of Medication Adherence in Hypertension , 2017, Front. Pharmacol..

[10]  M. Burnier,et al.  Adherence in Hypertension. , 2019, Circulation research.

[11]  María del Carmen Miranda Duro,et al.  Mobile Self-Monitoring ECG Devices to Diagnose Arrhythmia that Coincide with Palpitations: A Scoping Review , 2019, Healthcare.

[12]  F. Fedele,et al.  Triggers for Atrial Fibrillation: The Role of Anxiety , 2019, Cardiology research and practice.

[13]  H. Kennedy,et al.  Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact , 2017, Clinical cardiology.